GlassScriptPhysician profile
E Joy Ezomo
NPI 1508103904
$2,383.02
in general payments reported to CMS, 2019-2025
24 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $429 · 2023: $793 · 2024: $680 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,849.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $432.76 | 2023-2024 | Proclaim, Eterna |
| Collegium Pharmaceutical, INC. | $255.88 | 2021-2025 | Xtampza |
| Novo Nordisk INC | $249.96 | 2022-2023 | Wegovy |
| Abbvie INC. | $199.75 | 2021-2025 | |
| Nalu Medical, INC. | $158.99 | 2024 | Nalu Neurostimulation System |
| Teva Pharmaceuticals USA, INC. | $155.10 | 2022-2024 | Ajovy, Ajovy, Austedo Xr |
| Medtronic, INC. | $127.20 | 2022 | |
| Phathom Pharmaceuticals, INC. | $120.16 | 2025 | Voquezna |
| Relievant Medsystems, INC. | $110.63 | 2023 | Intracept |
| Ibsa Pharma INC. | $105.43 | 2024-2025 | Licart, Tirosint, Flector |
| Vertex Pharmaceuticals Incorporated | $78.09 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $74.85 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.28 | 2022 | |
| Pfizer INC. | $39.55 | 2025 | |
| Scilex Pharmaceuticals INC. | $36.88 | 2022-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $34.54 | 2025 | Tonmya |
| Amneal Pharmaceuticals LLC | $25.65 | 2023 | Lyvispah |
| Lilly USA, LLC | $23.60 | 2023 | Emgality, Reyvow |
| Arbor Pharmaceuticals, INC. | $20.92 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $20.71 | 2021 | |
| Vertos Medical, INC. | $19.56 | 2023 | Mild Device Kit |
| Biodelivery Sciences International, INC. | $17.03 | 2021 | |
| Stimwave Technologies Incorporated | $14.88 | 2022 | |
| Spr Therapeutics, INC | $8.62 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw E Ezomo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.